Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1985 1
1986 1
2010 1
2011 1
2015 2
2016 1
2017 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR, Lebel A, Rassekh SR, Schultz KR, Blydt-Hansen TD, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Palijan A, Lee J, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group. McMahon KR, et al. Among authors: boyko d. Pediatr Nephrol. 2023 May;38(5):1667-1685. doi: 10.1007/s00467-022-05745-5. Epub 2022 Oct 19. Pediatr Nephrol. 2023. PMID: 36260162
Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR, Rassekh SR, Schultz KR, Blydt-Hansen T, Cuvelier GDE, Mammen C, Pinsk M, Carleton BC, Tsuyuki RT, Ross CJD, Palijan A, Huynh L, Yordanova M, Crépeau-Hubert F, Wang S, Boyko D, Zappitelli M; Applying Biomarkers to Minimize Long-term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group. McMahon KR, et al. Among authors: boyko d. JAMA Netw Open. 2020 May 1;3(5):e203639. doi: 10.1001/jamanetworkopen.2020.3639. JAMA Netw Open. 2020. PMID: 32383745 Free PMC article.
Association between frailty and 30-day outcomes after discharge from hospital.
Kahlon S, Pederson J, Majumdar SR, Belga S, Lau D, Fradette M, Boyko D, Bakal JA, Johnston C, Padwal RS, McAlister FA. Kahlon S, et al. Among authors: boyko d. CMAJ. 2015 Aug 11;187(11):799-804. doi: 10.1503/cmaj.150100. Epub 2015 May 25. CMAJ. 2015. PMID: 26009583 Free PMC article.
Stress ulceration.
Boyko DA, Rowley-Jones D. Boyko DA, et al. Br J Hosp Med. 1985 Sep;34(3):186-7. Br J Hosp Med. 1985. PMID: 4063580 No abstract available.
Cost-effectiveness of blinatumomab versus salvage chemotherapy in relapsed or refractory Philadelphia-chromosome-negative B-precursor acute lymphoblastic leukemia from a US payer perspective.
Delea TE, Amdahl J, Boyko D, Hagiwara M, Zimmerman ZF, Franklin JL, Cong Z, Hechmati G, Stein A. Delea TE, et al. Among authors: boyko d. J Med Econ. 2017 Sep;20(9):911-922. doi: 10.1080/13696998.2017.1344127. Epub 2017 Jul 11. J Med Econ. 2017. PMID: 28631497 Free article. Clinical Trial.
11 results